Physician profile
Benjamin Boe Luong
NPI 1336439744
$2,682.11
in general payments reported to CMS, 2019-2025
40 companies · $510 in 2025
The $510 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $320 · 2020: $132 · 2021: $160 · 2022: $447 · 2023: $685 · 2024: $430 · 2025: $510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,607 · Gift: $16.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,607.17 |
| Gift | $16.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $346.18 | 2019-2025 | |
| Myriad Genetic Laboratories, INC. | $218.60 | 2023-2025 | Prolaris |
| Sumitomo Pharma America, INC. | $184.31 | 2023-2025 | Gemtesa, Orgovyx |
| Caldera Medical, INC | $158.96 | 2022-2023 | Desara |
| Astellas Pharma US INC | $155.54 | 2019-2025 | Xtandi |
| Urogen Pharma, INC. | $130.04 | 2021-2024 | |
| Accord Healthcare, INC. | $113.52 | 2023-2024 | |
| Janssen Biotech, INC. | $104.99 | 2019-2024 | Erleada |
| 180 Medical, INC. | $103.72 | 2019-2023 | Gentlecath Glide |
| Pfizer INC. | $85.85 | 2019-2024 | |
| Neotract INC. | $79.51 | 2019-2020 | |
| Boston Scientific Corporation | $72.58 | 2020-2025 | General - Female Sui |
| Teleflex LLC | $62.76 | 2022-2024 | Urolift |
| Blue Earth Diagnostics | $58.13 | 2025 | Posluma |
| Laborie Medical Technologies Corp. | $51.89 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Luong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.